← Back to Vaccine Database

ChAdOx1-S-(AZD1222)

Viral vector (Non-replicating) vaccine · VDDBV0149

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (Non-replicating) vaccine
COVID-19
ApprovedPhase 4 reached

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials36

NCT IDPhaseDisease / Condition
NCT04816019 Phase 1COVID-19
NCT04568031 Phase 2COVID-19
NCT04444674 Phase 2COVID-19
NCT04324606 Phase 2COVID-19
NCT04684446 Phase 2COVID-19
NCT04760730 Phase 2COVID-19
NCT05133609 Phase 2COVID-19
NCT04686773 Phase 2COVID-19
NCT04800133 Phase 2COVID-19
NCT04860739 Phase 2COVID-19
NCT04894435 Phase 2COVID-19
NCT04907331 Phase 2COVID-19
NCT04998240 Phase 2COVID-19
NCT05049226 Phase 2COVID-19
NCT05324319 Phase 2COVID-19
NCT05054621 Phase 2COVID-19
NCT05197153 Phase 2COVID-19
NCT05087368 Phase 2COVID-19
NCT05162482 Phase 2COVID-19
NCT04400838 Phase 3COVID-19
NCT04885764 Phase 3COVID-19
NCT05059106 Phase 3COVID-19
NCT05236491 Phase 3COVID-19
NCT04516746 Phase 3COVID-19
NCT04540393 Phase 3COVID-19
NCT04536051 Phase 3COVID-19
NCT04864561 Phase 3COVID-19
NCT05142319 Phase 3COVID-19
NCT04756271 Phase 3COVID-19
NCT05228730 Phase 3COVID-19
NCT04536051 Phase 3COVID-19
NCT04760132 ApprovedCOVID-19
NCT04775069 ApprovedCOVID-19
NCT04914832 ApprovedCOVID-19
NCT05057897 ApprovedCOVID-19
NCT05142488 ApprovedCOVID-19